Targeted Axillary Dissection — SCE Medical Oncology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Targeted axillary dissection (TAD) — combining removal of the clipped (biopsy-proven positive) node with sentinel lymph node biopsy to improve staging accuracy post-NACT, potentially avoiding full ALND
TAD combines clipped-node excision + SLNB post-NACT, reducing the false-negative rate of SLNB alone (from ~12% to ~2%). If the clipped node and sentinel nodes are negative, ALND can potentially be avoided, sparing patients lymphoedema morbidity. This technique is being adopted for initially node-positive patients who achieve axillary pathological complete response on NACT. NICE NG101 supports discussion of TAD in specialist centres.
Reference: ESMO 2024 Early Breast Cancer; Caudle et al JCO 2016; NICE NG101